Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Alexander S. Luchinin"'
Publikováno v:
International Journal of Online and Biomedical Engineering (iJOE). 19:141-157
Data generated from modern applications and the internet in healthcare is extensive and rapidly expanding. Therefore, one of the significant success factors for any application is understanding and extracting meaningful information using digital anal
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::468f291e9bdcd965e5979c0f20f6f30d
https://doi.org/10.3991/ijoe.v19i06.38157
https://doi.org/10.3991/ijoe.v19i06.38157
Autor:
Olga Senderova, Gysual Safuanova, Andrey Zaritsky, Elza Lomaia, Anton Kulikovsky, Elena Fedorova, Alexandr Korobkin, Marina Kozmina, Lubov Gavrilova, Eva Burnasheva, Elena Volodicheva, Galina Kuchma, Alexander S. Luchinin, Ludmila Napso, Dolgorzhap Dasheeva, Varvara I. Bakhtina, Ekaterina Chelysheva, Anna Lyamkina, Anton Shutilev, Marina Kosinova, Anatoly Golenkov, Vasilisa Skatova, Olga V. Lazareva, Svetlana Volkova, Sergei M. Kulikov, Tatiana Konstantinova, Sergey Voloshin, Vera Yablokova, Tatiana Klitochenko, Anna G. Turkina, Andrew Proidakov, Nataliya Glonina, Andrew Zhuravkov, Tatiana Chagorova, Olga Vinogradova
Publikováno v:
Blood. 138:5035-5035
The results of long-term follow-up of patients (pts) with chronic myeloid leukemia (CML) do not lose their importance. Data from routine clinical practice are of particular interest. The use of 1 st (imatinib, IM) and 2nd generation TKI (2G TKI) led
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a19128c61306200bf830a0b28868e780
https://doi.org/10.1182/blood-2021-151371
https://doi.org/10.1182/blood-2021-151371
Autor:
Sergei M. Kulikov, OYu Vinogradova, Alexander S. Luchinin, L V Gavrilova, MA Galaiko, A Tishchenko, SV Meresii, Olga V. Lazareva, Anna G. Turkina, V M Pepelyaeva, Olga Senderova, GI Milyutina, EYu Chelysheva, L B Avdeeva
Publikováno v:
Kliničeskaâ onkogematologiâ, Vol 10, Iss 2, Pp 65-74 (2017)
Background. Much attention has been paid to molecule-genetic diagnostics of chronic myeloid leukemia (CML) and its treatment using new highly effective methods of therapy. The baseline characteristics of patients at primary CML diagnosis are hardly d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8762dac182869b9afc23f4bef3eabc29
http://bloodjournal.ru/wp-content/uploads/2017/01/9.pdf
http://bloodjournal.ru/wp-content/uploads/2017/01/9.pdf
Autor:
Hunan Julhakyan, Galina I. Milutina, Oleg Shukhov, Lubov Gavrilova, Valentina Pepeliaeva, Olga Vinogradova, Alexander S. Luchinin, Anton Kulikovskiy, Lubov Avdeeva, Maria V. Galayko, Sergey Meresiy, Ekaterina Chelysheva, Olga Senderova, Sergey M. Kulikov, Anna G. Turkina, Elena B. Dasheeva, Olga V. Lazareva
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 19:S298-S299
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b2fbbb5ad4ea2509e119b9f505c82492
https://doi.org/10.1016/j.clml.2019.07.252
https://doi.org/10.1016/j.clml.2019.07.252
Autor:
Galina I. Milutina, Ekaterina Chelysheva, Sergei M. Kulikov, Valentina Pepeliaeva, L B Avdeeva, Anton Kulikovsky, Lubov Gavrilova, Olga Vinogradova, Sergey Meresiy, Dolgorzhap Dasheeva, Olga V. Lazareva, Alexander S. Luchinin, Anna G. Turkina, Olga Senderova
Publikováno v:
Blood. 134:5902-5902
Background: A success of the tyrosine kinase inhibitors (TKI) therapy in patients (pts) with chronic myeloid leukemia (CML) allowed to set a new goal: a treatment-free remission (TFR). A stable and long-lasting deep molecular response (DMR) is requir
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a5b90d338bacb27a4741ee02bea1b161
https://doi.org/10.1182/blood-2019-131430
https://doi.org/10.1182/blood-2019-131430
Publikováno v:
Journal of Clinical Practice. 6:95-10
Primary cutaneous CD4+ small/medium T-cell lymphoma is very rare blood disease with usually good prognosis. However similar histology and immunohistоchemistry of this pathology with more aggressive T-cells lymphomas, such as mycosis fungoides, make
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5b28a645bcdd4b0e90e18cedc6465cd9
https://doi.org/10.17816/clinpract83262
https://doi.org/10.17816/clinpract83262
Publikováno v:
Blood. 122:4999-4999
Introduction In some cases of the cytogenetic analysis patients with acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS) there are increase frequency non-clonal disorders (“cytogenetic noise”) in combination with complex (≥ 3 chromo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::255be4fb0d730090e16a450a60326b6a
https://doi.org/10.1182/blood.v122.21.4999.4999
https://doi.org/10.1182/blood.v122.21.4999.4999
Autor:
Lubov Gavrilova, Alexander S. Luchinin, Olga Senderova, Vanik A. Ovsepyan, Marya V. Galayko, Sergey V. Meresy, Valentyna M. Pepelyaeva, Sergey M. Kulikov, Galina I. Milutina, Irina A. Titshenko, L B Avdeeva, Olga Vinogradova, Ekaterina Chelysheva, Eduard G. Gendgan, Anna G. Turkina
Publikováno v:
Blood. 120:4431-4431
Abstract 4431 The European Treatment Outcome Study (EUTOS) is register based international investigation started in June 2007. [1] The aim is to study the epidemiology of CML and to gain insight into the ‘real world’ treatment of patients with CM
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2d7cc52958966cd62f42d7247eb16de7
https://doi.org/10.1182/blood.v120.21.4431.4431
https://doi.org/10.1182/blood.v120.21.4431.4431